Viral hepatitis remains a silent but urgent global health threat with millions of individuals undiagnosed or lost to follow-up. Healthcare professionals are challenged to bridge the gap between screening and treatment within vulnerable communities.
This TeleECHO series provides a comprehensive overview of current and emerging therapies for spondyloarthritis (SpA) conditions, translating the latest clinical data and guideline recommendations into practical, real-world applications for HCPs.
PI3K/AKT pathway inhibitors can lead to hyperglycemia, but you can be ready when or if it happens. Join us for this live webinar designed to elevate your skills to prevent and manage hyperglycemia in patients with metastatic HR+/HER2- breast cancer.
This live, "Ask the Expert" webinar offers the opportunity to engage directly with nationally recognized PTCL experts who will translate emerging evidence into practical guidance.
Build a compliant, profitable healthcare practice using cutting-edge strategies and tools for sustainable growth.
In this interactive session, join a multidisciplinary panel of HIV prevention and mental health experts to explore frameworks for implementation.
Endocrine resistance remains a key challenge in ER+/HER2- metastatic breast cancer, often driven by acquired ESR1 mutations. Early detection using ctDNA-based testing is essential for optimal integration of next-generation oral SERDs.
Join an interactive live webinar examining real-world challenges and evidence-based strategies to optimize HER2 testing and treatment decision-making in advanced and metastatic non-small cell lung cancer (NSCLC).
The latest Outpatient Medicine CME updates for nurse practitioners, physician assistants and other healthcare professionals. Taught LIVE by practicing physicians. Relevant, up-to-date studies. Live Stream available. Save $100 w/discount code: ENP100
Join us for an engaging live symposium at the ATS 2026 International Conference where you will hear leading RCC experts provide valuable insights related to diagnosis, underlying pathophysiology, and the latest treatment advances on the horizon.
